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There are 550,000 new cases of heart failure with
1,000,000 hospitalizations and 250,000 heart failure
deaths yearly in the USA with similar numbers in the
European Union. Cardiac resynchronization therapy
(CRT), based in the placement of A-V sequential,
biventricular pacemakers, is indicated to treat patients
with advanced, medically refractory heart failure,
reduced left ventricular (LV) function, and prolonged
QRS duration. Normally stimulated in an orderly pattern,
conduction is rapid through normal myocardium, bring-
ing near simultaneous, coordinate, and synchronous
myocardial contraction. Scarring leads to irregular con-
duction and varied sequences of dyssynchronous
contraction. CRT, seeks to improve mechanical syn-
chrony, but has other beneﬁts. CRT has been shown to
improve symptoms and survival, increase exercise tol-
erance, and quality of life, reduce hospitalization, and
bring reverse remodeling
1 in heart failure patients. Yet,
there is now nothing better to determine mechanical
synchrony and the potential for CRT improvement, than
ECG QRS duration, a crude and imperfect electrical
surrogate for mechanical dyssynchrony which excludes
many with heart failure and cannot optimize LV pace-
maker placement. The current broad inclusion criteria
bringvariable functional improvement in only 60-70% of
CRT patients.
2 CRT is invasive, costly, and risky. A
better indicator of CRT improvement is needed.
Imaging methods present clear potential to eval-
uate the contraction pattern and measure synchrony.
Echocardiography was applied early and widely to
evaluate synchrony and CRT. However, the varied
echocardiographic synchrony methods are not stan-
dardized, are operator dependent, lack reproducibility,
and are often lengthy, presenting complex measure-
ments, with limited sampling windows, high noise level,
and unproven sensitivity. While small observational
studies suggest that echocardiographic synchrony mea-
sures can identify CRT ‘‘responders’’ and predict
outcomes, their relation to CRT outcomes is irregular
with an inability to characterize the contraction abnor-
mality.
3 A recent multicenter study evaluated 12 popular
echocardiographic parameters of dyssynchrony, dem-
onstrating their inconsistency and inability to relate
prognosis or track outcome in CRT.
4 Yet, newer
Doppler methods and 3D show renewed promise.
5
MRI has the potential to express synchrony, and
several methods are now evolving. However, the
modality is costly, not widely available and is not gen-
erally recommended or widely applied to patients with
implanted devices.
Scintigraphic methods permit digitization of physi-
ologic and synchrony data. They are highly reproducible,
repeatable, and widely available. A count-based method
applies ﬁrst harmonic analysis to extract regional
amplitude and phase angle (Ø) from the curve-relating
myocardial intensity to systolic wall thickening on gated
SPECT myocardial perfusion scintigraphy.
6 The method
differentiated paced subjects and those with bundle
branch block, from normals with adequate reproducibil-
ity,
7 and demonstrated a sensitivity and speciﬁcity of
74%, for the prediction of response to CRT.
8 However,
dataqualitymayloseaccuracyduetoundersamplingwith
the conventional 8 frame acquisition and the relationship
between wall motion and thickening need not be linear.
Regional perfusion could vary with CRT in a manner not
proportional to regional function, or outcomes and func-
tion may not be measured accurately in underperfused
segments.
The mean and standard deviation of LV Ø (SD Ø),
derived from ﬁrst harmonic phase analysis and the phase
histogram of the ventricular time activity curve in
equilibrium radionuclide angiography (ERNA), have
been applied to characterize synchrony. Novel, objective
measures of regional contraction and global mechanical
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846synchrony, the synchrony (S) and entropy (E) parame-
ters have been developed and applied to planar ERNA as
a tool for evaluation and management of HF patients. S
expresses the efﬁciency of contraction within a region of
interest (ROI). S can estimate the contraction potential if
the ROI were synchronized. E measures the degree of
randomness within the ROI, from 0, with synchronous
motion and a single Ø, to 1 with fully dyssynchronous
contraction. It is designed to differentiate among forms
of extremely variable regional dyssnchrony. Initially
applied in a simulation model,
9 these parameters were
demonstrated to be highly reproducible and repeatable.
Compared to SD Ø, S and E were better able to differ-
entiate synchrony proﬁles among a spectrum of patterns
of abnormal wall motion. In preliminary clinical proto-
cols normal values were established and these measures
were shown to enhance CRT patient selection, to predict
and quantitate CRT outcomes, to optimize CRT pace-
maker lead placement based on location of the latest
contracting segment, to assess synchrony in HF patients
with narrow QRS, and to measure RV synchrony.
10-16
In this issue of the Journal
17 Wassenaar and cowork-
ers at the Ottawa Heart Institute sought to establish
optimal values for image smoothing, histogram noise
threshold, and bin size applied in the generation of SD Ø,
S, and E in normal subjects and patients with mechanical
dyssynchrony. At the optimal imaging values, the sensi-
tivity and speciﬁcity for all parameters for detection of
mechanical dyssynchrony were very high with inter- and
intra-observer correlation coefﬁcients approaching unity.
Optimized planar ERNA SD Ø, S, and E, detected
mechanical dyssynchrony with low inter- and intra-
observer variability.
Our group has a special interest in this manuscript
and its ﬁndings. After extensive experience in the appli-
cation of phase image analysis, we developed the S and E
parameters and have presented and published evidence of
their unique ability and application in CRT patients.
9-16
The results presented here further optimize and establish
the reproducibility of the method and move it forward,
closer to clinical application. While certainly not yet
proven, the parameters evaluated here have the capability
to quantitate synchrony and reproducibly follow it seri-
ally. With the phase image from which they are derived,
the latest contracting segment can be localized and CRT
pacemaker location optimized and the importance of RV
synchrony can be evaluated over a spectrum of cardiac
pathology. As noted by the authors, further studies
assessing the ability of these parameters to predict CRT
outcome are required and application of the method to
SPECTERNAcouldaddgreaterresolutionandaccuracy.
We have long been aware of the lack of objective,
reproducible methods to measure mechanical syn-
chrony, and their need.
18 Zaret
19 noted the importance
of such synchrony imaging software, and the ‘‘obvious
… suitability of [phase ERNA] for the study of patients
considered for CRT,’’ stating ‘‘… a more accurate …
deﬁnition of those who will beneﬁt [from CRT] is both a
clinical and economic necessity.’’ He urged, ‘‘Appro-
priate funding for such studies….’’ We certainly agree
but have already seen that the current economic crisis
will stiﬂe innovation and support in this important area
of imaging application.
20 There is every reason to
believe that methods such as that evaluated here, could
add objectivity and clarity to the selection and imple-
mentation of CRT. This could increase its success rate
with reduction in the variability of its beneﬁt. If suc-
cessful, this relatively inexpensive imaging method, or
others with such advantages, could more appropriately
and effectively apply a costly intervention to a large
vulnerable population. This presents great potential
beneﬁts of cost-effectiveness, most valuable in this time
of economic challenge. As expanded applications of
CRT loom,
21 such an approach may be expected to
evolve from an option to a necessity.
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